Industries > Pharma > Next-Generation Sequencing (NGS) Services Market Report 2020-2030

Next-Generation Sequencing (NGS) Services Market Report 2020-2030

Revenue Prospects by Service Type (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-based Sequencing Services, Animal & Plant Sequencing, Gene Regulation Services (Small RNA Sequencing Service, ChIP Sequencing, Other Gene Regulation-based Service), Other Sequencing Services), Workflow (Data Analysis Service, Pre Sequencing Service, Sequencing Service), End Users (Hospitals & Clinics, Pharma & Biotech, Universities & Other Research Facilities, Other End Users) and Geography

PAGES:
PRODUCT CODE: PHA0610

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0610 Categories: , Tag:

Next-Generation Sequencing Services– our new study reveals trends, R&D progress, and predicted revenues
Where is the Next-Generation Sequencing (NGS) Services market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 150+ page report provides 87 tables, 51 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Next-Generation Sequencing (NGS) Services Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
– You find original analyses, with business outlooks and developments.
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 3 segmentations of the Next-Generation Sequencing (NGS) Services market, with forecasts for 6 Service Types, 3 Workflows, 4 End Users, each forecasted at a global and regional level.

Global Next-Generation Sequencing (NGS) Services Market by Service Type
– Human Genome Sequencing Services
– Single Cell Sequencing Services
– Microbial Genome – based Sequencing Services
– Animal & Plant Sequencing
– Gene Regulation Services
– Small RNA sequencing service
– ChIP sequencing
– Other gene regulation – based service
– Other Sequencing Services

Global Next-Generation Sequencing (NGS) Services Market by Workflow
– Data Analysis Service
– Pre Sequencing Service
– Sequencing Service

Global Next-Generation Sequencing (NGS) Services Market by End Users
– Hospitals & Clinics
– Pharma & Biotech
– Universities & Other Research Facilities
– Other End Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

– North America:
– U.S.
– Canada

– Latin America:
– Brazil
– Mexico
– Rest of Latin America

– Europe:
– Germany
– France
– UK
– Italy
– Spain
– Russia
– Rest of Europe

– Asia-Pacific:
– Japan
– China
– India
– Australia
– ASEAN
– Rest of Asia-Pacific

– MEA:
– GCC Countries
– South Africa
– Rest of MEA

The report also includes profiles and for some of the leading companies in the Next-Generation Sequencing (NGS) Services market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030.

Leading companies and the potential for market growth
Overall world revenue for Next-Generation Sequencing (NGS) Services Market will surpass $1.5 billion in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Next-Generation Sequencing (NGS) Services Market report helps you
In summary, our 150+ page report provides you with the following knowledge:

– Revenue forecasts to 2030 for 3 segmentations of the Next-Generation Sequencing (NGS) Services market, with forecasts for 6 Service Types, 3 Workflows, 4 End Users, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

– Revenue forecasts to 2030 for 5 regional and 17 key national markets – See forecasts for the Next-Generation Sequencing (NGS) Services market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.

– Prospects for established firms and those seeking to enter the market– including company profiles for 20 major companies involved in the Next-Generation Sequencing (NGS) Services market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Next-Generation Sequencing (NGS) Services Market and leading companies. You will find data, trends and predictions.

Get our report today The Next-Generation Sequencing, NGS Services Market Analysis: Revenue Prospects by Service Type (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome – based Sequencing Services, Animal & Plant Sequencing, Gene Regulation Services (Small RNA sequencing service, ChIP sequencing, Other gene regulation – based service), Other Sequencing Services), Workflow (Data Analysis Service, Pre Sequencing Service, Sequencing Service), End Users (Hospitals & Clinics, Pharma & Biotech, Universities & Other Research Facilities, Other End Users), and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Next-Generation Sequencing (NGS) Services Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Next-Generation Sequencing (NGS) Services Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Visiongain Publishes Inhalation & Nasal Spray Generic Drugs Market Report 2021-2031

Rising prevalence of chronic respiratory diseases including asthma, COPD, and allergic rhinitis; rising geriatric population, escalating investment in drug R&D by biopharmaceutical & pharmaceutical companies; growing respiratory health care awareness; and new product launches worldwide are some of the major factors that boosting the growth of global inhalation & nasal spray generic drugs market.

31 March 2021

READ

Categories